APR-246 in Combination With Acalabrutinib or Venetoclax Based Therapy in Subjects With R/R Non Hodgkin Lymphomas (NHL)
Clinical trial NCT04419389 · TERMINATED
Trial details
- NCT number
- NCT04419389
- Sponsor
- Aprea Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-02
- Primary completion
- 2021-08-23
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.